Metraipolis › archive › dc_37353e27e920

Low-dose letrozole-HMG regimen reverses letrozole-induced endometrial impairment and improves frozen embryo transfer outcomes — Europe PMC PMID:41476607

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41476607
DOI
10.3389/fcell.2025.1725350
License (as archived)
solo-consultazione
Archived
2026-11-07T15:03:24.281Z
SHA-256 of the archived text
00359826bed954f439f0fb7b83e085ae8af53292ce9fd2750a62678323662c98
Stable URL of this page
https://metraipolis.com/documento/dc_37353e27e920

How to cite

Low-dose letrozole-HMG regimen reverses letrozole-induced endometrial impairment and improves frozen embryo transfer outcomes — Europe PMC PMID:41476607 — Europe PMC (en), https://europepmc.org/article/MED/41476607 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_37353e27e920 (Metraipolis archive dc_37353e27e920, sha256 00359826bed954f439f0fb7b83e085ae8af53292ce9fd2750a62678323662c98)
BibTeX
@misc{dc37353e27e920,
  title = {Low-dose letrozole-HMG regimen reverses letrozole-induced endometrial impairment and improves frozen embryo transfer outcomes — Europe PMC PMID:41476607},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41476607},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_37353e27e920; sha256 00359826bed954f439f0fb7b83e085ae8af53292ce9fd2750a62678323662c98},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41476607. Agents can read the archived copy with the MCP tool read_document.